From Our Thought Leader's

Merck's Commitment to Enhancing Cancer Outcomes at ASCO 2023

Merck, a leading science and technology company, today announced that 43 abstracts covering several modalities and mechanisms will be presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2-6, Chicago, Ill., US. New ... Read more

29 May, 2023 | Monday | News
SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company’s CEO, Jaeyong Ahn presented methods for equitable access of vaccine in the world at the Regi... Read more

23 May, 2023 | Tuesday | News
Gilead Appoints Cindy Perettie Executive Vice President of Kite

Ms. Perettie brings with her extensive experience in oncology and a commitment to improving patient care. Most recently, she was Head of Roche’s Molecular Lab Solutions where she oversaw the PCR (polymerase chain reaction) and Sequencing Busine... Read more

17 May, 2023 | Wednesday | News
Exothera Nucleic Acids Strengthens Team with Industry Expert

Exothera Nucleic Acids, the world's first nucleic acid CRDMO to provide continuous RNA manufacturing services from early discovery up to commercial cGMP, announced the appointment of Dr. Patrick Thiaville as Chief Technology Officer to support its gr... Read more

10 May, 2023 | Wednesday | News

Bio Finance

Seagen Stockholders Approve Acquisition by Pfizer

Following a special meeting of its stockholders, Seagen Inc. (Nasdaq: SGEN) today announced that its stockholders voted to approve a proposal to adopt the previously announced merger agreement under which Pfizer will acquire Seagen for $229 per share... Read more

31 May, 2023 | Wednesday | News
Merck Increases Global Commitment to Biosafety Testing With € 35 Million Investment in Scotland

Responds to global demand for biosafety testing for drug development and commercialization Expansion creates nearly 500 new jobs in Glasgow and Stirling Company’s investment to boost global testing capacity now tops € 350 million since... Read more

31 May, 2023 | Wednesday | News

Contract Services

Charles River Labs and Wheeler Bio to Build and Operate RightSourceSM Lab

Charles River Laboratories International, Inc. (NYSE: CRL) and Wheeler Bio, Inc., a contract development and manufacturing organization (CDMO),  announced an agreement to implement RightSourceSM at Wheeler Bio’s current good manufacturing ... Read more

01 June, 2023 | Thursday | News
Immutep Selects Charles River Laboratories for IMP761’s GLP Toxicology Study

Appointment of Charles River Laboratories ("Charles River") to run Immutep’s preclinical toxicology study evaluating the safety and toxicity of IMP761 Forms a key step prior to first-in-human trials for this first-in-class LAG-3 agonist anti... Read more

30 May, 2023 | Tuesday | News

BioPharma Video

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close